Biomaterial Co. MiMedx Accused Of Defrauding Investors
A MiMedx Group Inc. shareholder launched a class action Thursday accusing the biomaterial company of defrauding investors and causing stocks to plummet by making misleading statements about whether a range of...To view the full article, register now.
Already a subscriber? Click here to view full article